Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1819974
PUBLISHER: IMARC | PRODUCT CODE: 1819974
Irritable Bowel Syndrome Treatment Market Report by Type (IBS with Diarrhea, IBS with Constipation, Mixed IBS), Product, Distribution Channel, and Region 2025-2033
PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global irritable bowel syndrome treatment market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.8% during 2025-2033.
Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually caused by severe infection, stressful lifestyle, changes in gut microbes, muscle contractions in the intestine, and abnormalities in the nervous system. It can be characterized by gas, diarrhea, cramping, bloating, constipation, weight loss, vomiting, abdominal pain, and difficulty in swallowing. Several medications are currently available to relieve mild symptoms of IBS, including rifaximin, loperamide, laxatives, antispasmodics, fiber supplements, and coated peppermint oil capsules. Doctors also recommend probiotics and mental health therapies, such as cognitive behavioral-therapy (CBT), gut-directed hypnotherapy, and relaxation training, to treat certain patients.
Irritable Bowel Syndrome Treatment Market Trends:
Several factors increase the risk of IBS diseases, including food intolerances or sensitivities, bacterial infections in the digestive tract, small intestinal bacterial overgrowth, and mental disorders like anxiety, depression, and somatic symptom. This, along with improving diagnostic modalities and easy access to healthcare services, represents one of the key factors bolstering the growth of the market. Furthermore, IBS is one of the most common functional gastrointestinal disorders among the elderly. In confluence with this, the rising geriatric population across the globe is influencing the market positively. Besides this, several clinical trials, such as fecal microbiota transplantation (FMT), are being conducted to improve the treatment of IBS, which is contributing to market growth. In addition to this, as part of the Sustainable Development Goals (SDGs), governing agencies of various countries have pledged to substantially increase spending on research and development (R&D) projects and the number of researchers by 2030. This, in turn, is projected to expand the number of potential treatment options for IBS in the future.
Key Market Segmentation:
Breakup by Type:
- IBS with Diarrhea (IBS-D)
- IBS with Constipation (IBS-C)
- Mixed IBS
Breakup by Product:
- Rifaximin
- Eluxadoline
- Lubiprostone
- Linaclotide
- Others
Breakup by Distribution Channel:
- Hospitals Pharmacies
- Drug Stores and Retail Pharmacies
- Online Stores
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
- How has the global irritable bowel syndrome treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global irritable bowel syndrome treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global irritable bowel syndrome treatment market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A4297
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Irritable Bowel Syndrome Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 IBS with Diarrhea (IBS-D)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 IBS with Constipation (IBS-C)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Mixed IBS
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Product
- 7.1 Rifaximin
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Eluxadoline
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Lubiprostone
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Linaclotide
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospitals Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Drug Stores and Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Allergan plc (AbbVie Inc.)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Ardelyx Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Astellas Pharma Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 AstraZeneca plc
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Bausch Health Companies Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 GlaxoSmithKline Plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Novartis AG
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sebela Pharmaceuticals Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Synthetic Biologics Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.11 Takeda Pharmaceutical Company Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112025A4297
List of Figures
- Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2024
- Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2024
- Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2024
- Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2024
- Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
- Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
- Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
- Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million USD), 2025-2033
- Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
- Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.